{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:49:43Z","timestamp":1758638983774},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.transproceed.2014.09.065","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T17:31:24Z","timestamp":1415381484000},"page":"2912-2915","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Everolimus in Immunosuppressive Treatment After Kidney Transplantation in a Patient With Tuberous Sclerosis: Case Report"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Tarasewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bu\u0142anowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wi\u0119cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.09.065_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","article-title":"Tuberous sclerosis complex: advances in diagnosis, genetics, and management","volume":"57","author":"Schwartz","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00019052-200004000-00001","article-title":"Tuberous sclerosis complex","volume":"13","author":"Sparagana","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/era.11.93","article-title":"Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis","volume":"11","author":"Franz","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.transproceed.2014.09.065_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/oxfordjournals.ndt.a027315","article-title":"Chronic renal failure and its treatment in tuberous sclerosis","volume":"11","author":"Schillinger","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2014.09.065_bib5","first-page":"102","article-title":"Management of renal angiomyolipomas associated with tuberous sclerosis complex","volume":"171","author":"Harabayashi","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O\u2019Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.transproceed.2014.09.065_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00467-004-1795-3","article-title":"Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond","volume":"20","author":"Henske","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199003000-00008","article-title":"Outcome of patients with tuberous sclerosis after renal transplantation","volume":"49","author":"Balligand","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.065_bib9","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.transproceed.2006.08.121","article-title":"Bourneville-Pringle disease for kidney transplantation: a single-center experience","volume":"38","author":"Dallos","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.065_bib10","first-page":"193","article-title":"Anesthetic management of a patient with tuberous sclerosis presenting for renal transplantation","volume":"17","author":"Papaioannou","year":"2003","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.transproceed.2014.09.065_bib11","first-page":"43","article-title":"Successful live related renal transplant in a case of tuberous sclerosis","volume":"53","author":"Minz","year":"2005","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.transproceed.2014.09.065_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1442-2042.2007.01951.x","article-title":"Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas","volume":"15","author":"Saito","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.trre.2010.11.001","article-title":"Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stone","volume":"25","author":"Haidinger","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2014.09.065_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1432-2277.2009.01041.x","article-title":"Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity","volume":"23","author":"Haidinger","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.09.065_bib15","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1093\/ndt\/gfm552","article-title":"Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and lifethreatening abdominal haemorrhages","volume":"22","author":"Corsenca","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2014.09.065_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.transproceed.2014.09.065_bib17","first-page":"397087","article-title":"Tuberous sclerosis associated with polycystic kidney disease: effects of rapamycin after renal transplantation","volume":"2013","author":"Rosado","year":"2013","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.transproceed.2014.09.065_bib18","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.transproceed.2009.06.227","article-title":"Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex","volume":"41","author":"Tarasewicz","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.065_bib19","first-page":"211","article-title":"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex","volume":"7","author":"Franz","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.transproceed.2014.09.065_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2014.09.065_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2014.09.065_bib22","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2012-3607","article-title":"Possible prevention of tuberous sclerosis complex lesions","volume":"132","author":"Kotulska","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.transproceed.2014.09.065_bib23","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1111\/ctr.12223","article-title":"Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials","volume":"27","author":"Cooper","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2014.09.065_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1824-7288-39-57","article-title":"Is mTOR inhibition a systemic treatment for tuberous sclerosis?","volume":"39","author":"Moavero","year":"2013","journal-title":"Ital J Pediatr"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514008513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514008513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T23:50:38Z","timestamp":1538092238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514008513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0041134514008513"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.065","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus in Immunosuppressive Treatment After Kidney Transplantation in a Patient With Tuberous Sclerosis: Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}